Other languages LSL Pharma Group Inc.

Equities

LSL

CA50190N1042

End-of-day quote Toronto S.E. Other stock markets 03:30:00 07/06/2024 am IST			5-day change	1st Jan Change
0.5 ^CAD	+2.04%		-1.96%	+3.09%

05/06	LSL Pharma to Raise $4.5 Million Via Private Placements	MT
05/06	LSL Pharma Group Inc. announced that it expects to receive CAD 3 million in funding	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

LSL Pharma to Raise $4.5 Million Via Private Placements	05/06
LSL Pharma Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/05
LSL Pharma Group Inc. Appoints Diane Beaudry and Mario Paradis to Its Board of Directors	23/04
Gestion Jacques Grimard Inc. acquiert des unités de Groupe LSL Pharma Inc.	20/03
LSL Pharma Loses 5% As Raises $6.44 Million In First Closing Of Private Placements	19/03
Le Groupe LSL Pharma clôture un financement de 6,44 millions $ comme première tranche de placements privés concomittants sans courtier	19/03
Le groupe LSL Pharma annonce une combinaison de placements privés pour un produit brut total maximum de 8 millions $	07/03
LSL Pharma Group Announced An Extension Of Its Convertible Debentures Offering	09/01
Le Groupe LSL Pharma annonce la prolongation de son placement de débentures convertibles	08/01
LSL Pharma Group Up 4.7% After Reporting Closing of Second Tranche of Convertible Debentures Offering	08/12
Le Groupe LSL Pharma annonce la clôture de la deuxième tranche du placement de débentures convertibles	08/12
LSL Pharma Group Appoints Luc Mainville as Chief Financial Officer	04/12
Le Groupe LSL Pharma annonce la nomination de Luc Mainville à titre de chef de la direction financière	04/12
LSL Pharma Group Inc. Appoints Luc Mainville as Senior Vice President, Effective December 4, 2023	04/12
LSL Pharma Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11
Groupe LSL Pharma dévoile ses résultats du troisième trimestre de l’exercice 2023	29/11
Le Groupe LSL Pharma annonce la clôture de la première tranche du placement de débentures convertibles	01/11
Groupe LSL Pharma up 10% in Early Trade as Announces New Orders With Annual Revenue Potential of Over $2.6 Million	25/23/25
Groupe LSL Pharma annonce de nouvelles commandes pouvant totaliser plus de 2,6 M$ sur une base annuelle	25/23/25
Lsl Laboratory Receives New Orders for Natural Health Products. Unless Otherwise Specified, All Amounts Are in Canadian Dollars	25/23/25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages LSL Pharma Group Inc.

Equities

LSL

CA50190N1042

Other languages

Filters